-

Investor Notice: Robbins LLP Informs Investors of the Securities Class Action Against Oracle Corporation

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all persons and/or entities who purchased or otherwise acquired Oracle Corporation (NYSE: ORCL) Senior Notes issued pursuant to the Shelf Registration Statement filed with the SEC on March 15, 2024, and as supplemented on September 25, 2025. Oracle is an Austin, Texas-based company that sells database software, enterprise applications, and cloud infrastructure and hardware.

Robbins LLP is Investigating Allegations that Oracle Corporation (ORCL) Misled Investors Regarding the Amount of Money Needed for its AI Buildout

Share

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that Oracle Corporation (ORCL) Misled Investors Regarding the Amount of Money Needed for its AI Buildout

According to the complaint, on September 10, 2025, Oracle and OpenAI OpCo, LLC announced a $300 billion, five-year cloud computing contract, to supply OpenAI with computing power. On September 25, 2025, Oracle issued Senior Notes, comprising of $18 billion in bonds, to fund its AI infrastructure expansion. Plaintiff alleges that the Offering did not disclose that further significant debt would be required to fund the Oracle–OpenAI agreement.

The complaint alleges that unbeknownst to investors, Oracle needed to raise a significant amount of additional debt to build the AI infrastructure. Specifically, on November 13, 2025 (just seven weeks after issuing the Senior Notes), reports emerged that Oracle was looking to raise an additional $38 billion in debt sales to help fund its AI buildout. The $38 billion would consist of $23 billion and $15 billion term loans led by various banks. Proceeds from the loan would fund two data centers developed by Vantage Data Centers in Wisconsin and Texas—data centers that would support the Oracle–Open AI agreement. On this news, Oracle's Senior Notes began to trade with yields and spreads similar to lower-rated issuers as investors began to demand higher yields due to perceived credit risk.

What Now: You may be eligible to participate in the class action against Oracle Corporation. Bondholders who wish to serve as lead plaintiff for the class should contact Robbins LLP. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.

To be notified if a class action against Oracle Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:ORCL

Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Vistagen Therapeutics, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025. Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron Dumas...

Investor Notice: Robbins LLP Informs Investors of the Smart Digital Group Limited Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Smart Digital Group Limited (NASDAQ: SDM) securities between May 5, 2025 and September 26, 2025. Smart Digital, together with its subsidiaries, provides internet media, business planning and consulting, event planning and execution, and software customization and marketing services in Mainland China and Macau. For more information, submit a fo...

Investor Notice: Robbins LLP Informs Investors of the CoreWeave, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired CoreWeave, Inc. (NASDAQ: CRWV) securities between March 28, 2025 and December 15, 2025. CoreWeave purports to be an artificial intelligence (“AI”) cloud computing company and self-described “Hyperscaler”, which it defines as “a cloud provider or technology company that is capable of delivering computing infrastructure and services at massive s...
Back to Newsroom